Advertisement

15 Medicare Drug Prices 2027: Ozempic Drops to $274 on Jan 1

Picture this: a retiree picks up her Ozempic refill in January 2027 and the pharmacy's total drops from $959 a month to $274. Not a coupon. Not a one-time assistance program. The actual price Medicare negotiated with the drugmaker.

That isn't a rumor — it's official. On November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) locked in new maximum fair prices for 15 of the most expensive drugs in Medicare Part D. The prices take effect January 1, 2027, and they include Ozempic, Wegovy, Rybelsus, Trelegy Ellipta, and 11 more. The discounts range from 38% to 85% off list prices.

And here's why the timing matters for you specifically: these new prices land right in the middle of your open-enrollment decision. You have until December 7, 2026 to pick the plan that takes advantage of them. Choose the wrong plan now and you won't see another chance until next October. So let's go through the full list, the savings math, and the one catch the headlines skip.

How Did Medicare Get These Prices?

For most of its history, Medicare was legally forbidden from negotiating drug prices — it just paid whatever the manufacturer charged. The 2022 Inflation Reduction Act changed that, creating the Medicare Drug Price Negotiation Program.

The first round covered 10 drugs and took effect January 1, 2026. These 15 are round two. Together, they represent about $42.5 billion in annual Medicare Part D spending — roughly 15 cents of every dollar the program spends on drugs. CMS estimates the negotiations save Medicare itself about $12 billion, and beneficiaries roughly $685 million in out-of-pocket costs in 2027.

Round three starts in 2028, and it expands beyond pharmacy drugs to include certain physician-administered drugs under Part B. The negotiation program isn't a one-off — it's a permanent fixture now.

The Full List: 15 Drugs, Old Price vs. 2027 Price

These are 30-day supply figures. The "old" price is the 2024 manufacturer list price; the new one is Medicare's negotiated price starting January 1, 2027.

DrugTreats2024 list2027 price
Ozempic, Rybelsus, WegovyDiabetes, heart disease, weight management$959$274
Trelegy ElliptaCOPD, asthma$654$175
XtandiProstate cancer$13,480$7,004
PomalystMultiple myeloma$21,744$8,650
OfevLung scarring$12,622$6,350
IbranceBreast cancer$15,741$7,871
LinzessIBS, chronic constipation$539$136
CalquenceLeukemia, lymphoma$14,228$8,600
Austedo / Austedo XRMovement disorders$6,623$4,093
Breo ElliptaCOPD, asthma$397$67
XifaxanIBS, liver-related conditions$2,696$1,000
VraylarDepression, bipolar, schizophrenia$1,376$770
TradjentaType 2 diabetes$488$78
Janumet / Janumet XRType 2 diabetes$526$80
Otezla / Otezla XRPsoriasis, psoriatic arthritis$4,722$1,650

A few standouts: Janumet drops 85% ($526 → $80), Tradjenta falls 84% ($488 → $78), and Breo Ellipta collapses 83% ($397 → $67). The semaglutide trio — Ozempic, Rybelsus, Wegovy — is the single biggest line item on the list, falling 71% to $274.

The Catch the Headlines Skip

Okay, here's the part that matters most, because the headlines can mislead: the negotiated price is not your copay. CMS calls it the "maximum fair price" — it's what Medicare and your drug plan pay the manufacturer. What comes out of your wallet still depends on your plan's design: your deductible, the drug's tier on your plan's formulary, your copay or coinsurance, and the pharmacy you use.

So what do you actually get? Two real things. First, every Part D plan and every Medicare Advantage plan with drug coverage is legally required to include these 15 drugs in its formulary once the new prices take effect — they can't just drop Ozempic to dodge the deal. Second, the lower plan cost feeds through to your share, especially once you hit the 2027 out-of-pocket cap of $2,400 (up from $2,100), after which covered drugs cost you $0 for the rest of the year. The Part D deductible rises to $700 in 2027.

One more honest caveat: Wegovy for weight loss alone still isn't covered. Medicare Part D doesn't cover GLP-1 drugs prescribed purely for weight management rather than diabetes or cardiovascular disease, and the negotiated price doesn't change that rule. There's a separate temporary program offering a $50/month GLP-1 option for eligible weight-loss prescriptions through December 31, 2027 — worth asking your doctor about, but it's a different door.

What to Do Before December 7

Here's the practical part. Open enrollment for 2027 coverage runs October 15 through December 7, 2026 — and you're in it right now. If any of these 15 drugs are on your medication list, this decision just got more important than usual.

1. Look up your plan's 2027 formulary. The negotiated price helps most when your plan covers the drug on a reasonable tier. Every plan posts its 2027 formulary during open enrollment — check where your specific drugs land. If your current plan puts one of these on a high specialty tier, a competing plan might treat it better.

2. Run your drugs through Medicare's Plan Finder. Enter your actual prescriptions at medicare.gov/plan-compare and let it show you total 2027 costs by plan — premiums plus what you'd actually pay for your drugs. Don't renew on autopilot this year; the math changed.

3. Ask your pharmacist, not just your plan. Pharmacists see the real out-of-pocket numbers across dozens of plans every day. A five-minute call can surface things the brochures bury — like which pharmacy in your zip code gets the lowest price on your exact drug.

4. If you'll hit the $2,400 cap, ask about the payment plan. The Medicare Prescription Payment Plan lets you spread your drug costs across monthly payments instead of getting crushed in January and February. No interest, no fees — just ask your plan to enroll you.

And if Medicare Advantage members are wondering about one more open door: you get an additional switching window, the Medicare Advantage Open Enrollment Period, from January 1 through March 31, 2027. Stand-alone Part D enrollees don't get that one, so get it right by December 7.

While you're reviewing your coverage, it's also worth revisiting our open-enrollment checklist — the negotiated-price change is one of several 2027 shifts worth catching before the deadline. And if you haven't seen it, CMS sent a one-time $90 Medicare rebate to millions of seniors this fall — a separate, automatic payment that may still be on its way to you.

FAQ: Medicare Drug Prices 2027

Will my Ozempic copay actually go down on January 1, 2027?

Probably, but not to $274. That number is what Medicare pays the manufacturer — your copay is set by your Part D plan's tier structure. The negotiated price pushes your plan's costs down, which should lower what you pay, but the exact number depends on your plan. Check your plan's 2027 formulary during open enrollment to see the real figure.

Do I need to apply or enroll to get the new prices?

No. If you have a Medicare Part D plan or a Medicare Advantage plan with drug coverage, the negotiated prices apply automatically on January 1, 2027. There's no application, no paperwork, and no action needed. Anyone who contacts you asking you to "register" for these prices is running a scam.

Does this cover Wegovy prescribed just for weight loss?

No. Medicare Part D still excludes GLP-1 drugs prescribed solely for weight management. The negotiated semaglutide price applies to covered indications — type 2 diabetes and cardiovascular disease. A separate temporary Medicare program offers a $50/month GLP-1 option for eligible weight-loss prescriptions through December 31, 2027.

What if my plan doesn't cover one of these drugs?

That shouldn't happen starting January 1, 2027 — every Part D and Medicare Advantage drug plan is required to include these 15 negotiated drugs in its formulary. If you find a plan missing one, that's a problem to raise with Medicare directly at 1-800-MEDICARE.

How much will seniors actually save?

CMS projects about $685 million in out-of-pocket savings across all beneficiaries in 2027 — roughly $130 per person taking one of these drugs, on average. Your personal savings depend on which drug you take and your plan's cost-sharing. The plan-level savings are much bigger: $12 billion for Medicare itself, which is what keeps the program's costs — and eventually premiums — in check.

Disclaimer: This article is for educational purposes only and is not medical or financial advice. Drug coverage, formularies, and costs vary by plan. Confirm your 2027 costs with your plan, your pharmacist, or Medicare at medicare.gov or 1-800-MEDICARE before making decisions.

Post a Comment

0 Comments